DAWN
ANALYST COVERAGE11 analysts
BUY
-0.1%downside to target
Buy
655%
Hold
545%
6 Buy (55%)5 Hold (45%)0 Sell (0%)
Full report →
PRICE
Prev Close
21.53
Open
21.53
Day Range
52W Range5.64 – 21.53
5.64
21.53
100% of range
VOLUME & SIZE
Avg Volume
4.0M
FUNDAMENTALS
P/E Ratio
-20.7x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
0.24
Low vol
TECHNICAL
RSI (14)
80
Overbought
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 114 days
Sep 9
Key MetricsTTM
Market Cap$2.22B
Revenue TTM$158.18M
Net Income TTM-$107.32M
Free Cash Flow-$107.58M
Gross Margin89.1%
Operating Margin-80.8%
Net Margin-67.8%
Return on Equity-23.4%
Return on Assets-21.1%
Debt / Equity0.01
Current Ratio8.02
EPS TTM$-1.04

DAWN News

About

No description available.

Davy ChiodinChief Development Officer
Elly BarryChief Medical Officer
Adam DubowGeneral Counsel
Heather Adkins HuetChief Scientific Officer
Jeremy BenderChief Executive Officer, President & Director
Michael J. VasconcellesHead of Research & Development
Charles N. YorkChief Operating Officer & Chief Financial Officer
Joey PerroneSenior Vice President of Finance & Investor Relations
John StubenrauchChief Technology Officer
Jaa RobersonChief People Officer
Lauren MerendinoChief Commercial Officer